A micro‑peptide encoded by HOXB‑AS3 promotes the proliferation and viability of oral squamous cell carcinoma cell lines by directly binding with IGF2BP2 to stabilize c‑Myc

Leng,Fei; Miu,Yan-Yu; Zhang,Yi; Luo,Hao; Lu,Xiao-Li; Cheng,Hui; Zheng,Zhi-Guo

doi:10.3892/ol.2021.12958

A micro‑peptide encoded by HOXB‑AS3 promotes the proliferation and viability of oral squamous cell carcinoma cell lines by directly binding with IGF2BP2 to stabilize c‑Myc

Authors:
- Fei Leng
- Yan-Yu Miu
- Yi Zhang
- Hao Luo
- Xiao-Li Lu
- Hui Cheng
- Zhi-Guo Zheng
View Affiliations

Affiliations: The Affiliated Stomatological Hospital of Nanchang University, The Key Laboratory of Oral Biomedicine, Nanchang, Jiangxi 330006, P.R. China
Published online on: August 2, 2021 https://doi.org/10.3892/ol.2021.12958
Article Number: 697
Copyright: © Leng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

HOXB‑AS3 is a long non‑coding RNA and recent studies have shown that the HOXB‑AS3‑encoded micro‑peptide was associated with the progression of colon cancer tumorigenesis; however, the biofunction of HOXB‑AS3 varies in different types of cancer and the potential function in oral squamous cell carcinoma (OSCC) is still unknown. The Cancer Genome Atlas (TCGA) database was searched and the expression patterns of HOXB‑AS3 in head and neck carcinoma were analyzed. Reverse transcription‑quantitative PCR and western blot analysis was used to measure the mRNA and protein expression level of HOXB‑AS3 in patients with OSCC, respectively. Next, HOXB‑AS3 was knocked down in 2 OSCC cell lines to investigate the biological function of the HOXB‑AS3‑encoded protein using a Cell Counting Kit‑8 and colony formation assays. To further identify the potential mechanism of the HOXB‑AS3‑encoded protein, co‑immunoprecipitation was also used to detect the interaction between HOXB‑AS3 and IGF2BP2, while HOXB‑AS3 was re‑expressed to determine whether the HOXB‑AS3‑encoded protein and not HOXB‑AS3 exerted its function in OSCC. HOXB‑AS3 was upregulated in OSCC tissues, in both TCGA database and in patients with OSCC recruited into the present study. HOXB‑AS3 was associated with poor prognosis in OSCC. The proliferation and viability decreased in the 2 OSCC cell lines following knock down of HOXB‑AS3. HOXB‑AS3 was also found to encode a protein that directly interacted with IGF2BP2 and thereby promoted the stability of c‑myc. Taken together, the results from the present study indicated that increased HOXB‑AS3 expression was associated with poor prognosis in OSCC. This indicated that HOXB‑AS3 and its encoded protein promoted OSCC cell proliferation and viability by maintaining c‑Myc mRNA stability by directly binding to IGF2BP2.

View Figures

View References

1	Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
2	Li P, Fang Q, Yang Y, Chen D, Du W, Liu F and Luo R: Survival significance of number of positive lymph nodes in oral squamous cell carcinoma stratified by p16. Front Oncol. 11:5454332021. View Article : Google Scholar : PubMed/NCBI
3	Antonsson A, de Souza M, Wood ZC, Carroll A, Van K, Paterson L, Pandeya N and Whiteman DC: Natural history of oral HPV infection: Longitudinal analyses in prospective cohorts from Australia. Int J Cancer. 148:1964–1972. 2021. View Article : Google Scholar : PubMed/NCBI
4	Panarese I, Aquino G, Ronchi A, Longo F, Montella M, Cozzolino I, Roccuzzo G, Colella G, Caraglia M and Franco R: Oral and Oropharyngeal squamous cell carcinoma: Prognostic and predictive parameters in the etiopathogenetic route. Expert Rev Anticancer Ther. 19:105–119. 2019. View Article : Google Scholar : PubMed/NCBI
5	Yang H, Zhang Z, Peng R, Zhang L, Liu H, Wang X, Tian Y and Sun Y: RNA-Seq analysis reveals critical transcriptome changes caused by sodium butyrate in DN mouse models. Biosci Rep. 30:BSR202030052021. View Article : Google Scholar
6	Yan T, Shen C, Jiang P, Yu C, Guo F, Tian X, Zhu X, Lu S, Han B, Zhong M, et al: Risk SNP-induced lncRNA-SLCC1 drives colorectal cancer through activating glycolysis signaling. Signal Transduct Target Ther. 6:702021. View Article : Google Scholar : PubMed/NCBI
7	Qin Y, Hou Y, Liu S, Zhu P, Wan X, Zhao M, Peng M, Zeng H, Li Q, Jin T, et al: A novel long non-coding RNA lnc030 maintains breast cancer stem cell stemness by stabilizing SQLE mRNA and increasing cholesterol synthesis. Adv Sci (Weinh). 8:20022322020. View Article : Google Scholar : PubMed/NCBI
8	Zhang F, Wang H, Yu J, Yao X, Yang S, Li W, Xu L and Zhao L: LncRNA CRNDE attenuates chemoresistance in gastric cancer via SRSF6-regulated alternative splicing of PICALM. Mol Cancer. 20:62021. View Article : Google Scholar : PubMed/NCBI
9	Huang JZ, Chen M, Chen D, Gao XC, Zhu S, Huang H, Hu M, Zhu H and Yan GR: A peptide encoded by a putative lncRNA HOXB-AS3 suppresses colon cancer growth. Mol Cell. 68:171–184, e6. 2017. View Article : Google Scholar : PubMed/NCBI
10	Xu S, Jia G, Zhang H, Wang L, Cong Y, Lv M, Xu J, Ruan H, Jia X, Xu P and Wang Y: LncRNA HOXB-AS3 promotes growth, invasion and migration of epithelial ovarian cancer by altering glycolysis. Life Sci. 264:1186362021. View Article : Google Scholar : PubMed/NCBI
11	Papaioannou D, Petri A, Dovey OM, Terreri S, Wang E, Collins FA, Woodward LA, Walker AE, Nicolet D, Pepe F, et al: The long non-coding RNA HOXB-AS3 regulates ribosomal RNA transcription in NPM1-mutated acute myeloid leukemia. Nat Commun. 10:53512019. View Article : Google Scholar : PubMed/NCBI
12	Beltramini GA, Belloni LM, Fusco N, Sacconi A, Muti P, Baj A, Bolzoni AR and Giannì AB: Comparing prognostic utility between the 8th edition of TNM staging system and the lymph node ratio for oral squamous cell carcinoma. Head Neck. Jun 11–2021.(Epub ahead of Print). View Article : Google Scholar : PubMed/NCBI
13	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
14	Huang H, Weng H, Sun W, Qin X, Shi H, Wu H, Zhao BS, Mesquita A, Liu C, Yuan CL, et al: Recognition of RNA N⁶-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol. 20:285–295. 2018. View Article : Google Scholar : PubMed/NCBI
15	Cheng J, Zhou X, Feng W, Jia M, Zhang X, An T, Luan M, Pan Y, Zhang S, Zhou Z, et al: Risk stratification by long non-coding RNAs profiling in COVID-19 patients. J Cell Mol Med. 25:4753–4764. 2021. View Article : Google Scholar : PubMed/NCBI
16	Starzynska A, Adamska P, Sejda A, Sakowicz-Burkiewicz M, Adamski ŁJ, Marvaso G, Wychowański P and Jereczek-Fossa BA: Any role of PIK3CA and PTEN biomarkers in the prognosis in oral squamous cell carcinoma? Life (Basel). 10:3252020.PubMed/NCBI
17	Manikandan M, Deva Magendhra Rao AK, Arunkumar G, Manickavasagam M, Rajkumar KS, Rajaraman R and Munirajan AK: Oral squamous cell carcinoma: MicroRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism. Mol Cancer. 15:282016. View Article : Google Scholar : PubMed/NCBI
18	Saravani S, Parsamanesh N and Miri-Moghaddam E: Role of EGFR gene polymorphisms in oral squamous cell carcinoma patients of Southeast Iran: A case-control study. Caspian J Intern Med. 11:391–397. 2020.PubMed/NCBI
19	Ren X, Li L, Wu J, Lin K, He Y and Bian L: PDGF-BB regulates the transformation of fibroblasts into cancer-associated fibroblasts via the lncRNA LURAP1L-AS1/LURAP1L/IKK/IκB/NF-κB signaling pathway. Oncol Lett. 22:5372021. View Article : Google Scholar : PubMed/NCBI
20	Che H, Che Y, Zhang Z and Lu Q: Long non-coding RNA LINC01929 accelerates progression of oral squamous cell carcinoma by targeting the miR-137-3p/FOXC1 axis. Front Oncol. 11:6578762021. View Article : Google Scholar : PubMed/NCBI
21	Ai Y, Wei H, Wu S, Tang Z, Li X and Zou C: Exosomal lncRNA LBX1-AS1 derived from RBPJ overexpressed-macrophages inhibits oral squamous cell carcinoma progress via miR-182-5p/FOXO3. Front Oncol. 11:6058842021. View Article : Google Scholar : PubMed/NCBI
22	Yu Q, Du Y, Wang S and Zheng X: LncRNA PART1 promotes cell proliferation and inhibits apoptosis of oral squamous cell carcinoma by blocking EZH2 degradation. J Biochem. Mar 16–2021.(Epub ahead of Print). View Article : Google Scholar
23	Lu S, Zhang J, Lian X, Sun L, Meng K, Chen Y, Sun Z, Yin X, Li Y, Zhao J, et al: A hidden human proteome encoded by ‘non-coding’ genes. Nucleic Acids Res. 47:8111–8125. 2019. View Article : Google Scholar : PubMed/NCBI
24	Jiang W, Kai J, Li D, Wei Z, Wang Y and Wang W: lncRNA HOXB-AS3 exacerbates proliferation, migration, and invasion of lung cancer via activating the PI3K-AKT pathway. J Cell Physiol. 235:7194–7203. 2020. View Article : Google Scholar : PubMed/NCBI